Mode of action of methotrexate–albumin in a human T-cell leukemia line and activity against an MTX-resistant clone

Author： Weigand M.   Hartung1 G.   Roboz2 J.   Sieger S.   Wolf M.   Sinn3 H.   Schrenk3 H-H.   Wiessler M.   Frei E.  

Publisher： Cognizant Communication Corporation

ISSN： 1460-2148

Source： Anti-Cancer Drug Design, Vol.16, Iss.4, 2001-08, pp. : 227-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efalizumab: T-cell clone proliferation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1354, 2011-01 ,pp. : 20-21

Adis International

Access to resources Recommend Favorite

Is there a role for ubiquitin or SUMO in human T-cell leukemia virus type 2 Tax-induced NF-&kgr;B activation?

By Lavorgna Alfonso   Harhaj Edward W  

Future Virology, Vol. 8, Iss. 3, 2013-03 ,pp. : 223-227

Future Medicine

Access to resources Recommend Favorite

New insights into the pathogenesis, diagnosis and treatment of human T-cell leukemia virus type 1-induced disease

By Pandya Devanshi   Rahman Saifur   Wigdahl Brian   Khan Zafar K   Jain Pooja  

Future Virology, Vol. 2, Iss. 5, 2007-09 ,pp. : 481-493

Future Medicine

Access to resources Recommend Favorite

Roles of miRNAs in virus-mediated cellular transformation: lessons from human T-cell leukemia virus type 1

By Yeung Man Lung   Jeang Kuan-Teh  

Future Virology, Vol. 6, Iss. 11, 2011-11 ,pp. : 1351-1360

Future Medicine

Access to resources Recommend Favorite

The Protease of Human T-Cell Leukemia Virus Type-1 is a Potential Therapeutic Target

By  

Current Pharmaceutical Design, Vol. 13, Iss. 12, 2007-04 ,pp. : 1285-1294

Bentham Science Publishers

Access to resources Recommend Favorite